Tenon Medical (TNON) Net Equity Issued and Repurchased (2023 - 2025)

Tenon Medical's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2025.

• On a quarterly basis, Net Equity Issued and Repurchased rose 53.93% year-over-year to $4.0 million in Q1 2025; TTM through Jun 2025 was $4.1 million, a 277.62% increase from a year earlier, with the FY2024 full-year figure at $2.1 million, up 325.45% from the prior year.
• Net Equity Issued and Repurchased advanced to $4.0 million in Q1 2025 per TNON's latest filing, from -$499000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $4.0 million in Q1 2025 and bottomed at -$4.4 million in Q3 2023.
• The 3-year median for Net Equity Issued and Repurchased is $42000.0 (2023), against an average of $257571.4.
• Biggest YoY gain for Net Equity Issued and Repurchased was 114.12% in 2024; the steepest drop was 1288.1% in 2024.
• Year by year, Net Equity Issued and Repurchased stood at $42000.0 in 2023, then slumped by 1288.1% to -$499000.0 in 2024, then soared by 903.61% to $4.0 million in 2025.
• Per Business Quant, the three latest TNON Net Equity Issued and Repurchased figures stand at $4.0 million (Q1 2025), -$499000.0 (Q4 2024), and $615000.0 (Q3 2024).